PPT-Responding to the Opioid Addiction Epidemic

Andrew Kolodny MD Chief Medical Officer Phoenix House Foundation New York NY The Opium Poppy Papaver Somniferum 2 Crude Opium Latex on Poppy Head 3 Opioids Morphine Codeine Thebaine. Kenneth L. Kirsh. , . Ph.D.. Clinical Research Educator and Research Scientist. Millennium . Laboratories. Millennium Research Institute. San Diego, CA. The Opioid Pendulum. Opiophobia. Balance of Addiction Medicine and Pain Management Principles. David Kan, M.D.. University of California. San Francisco. VA Medical Center. San Francisco. History of Opioids. The “Pod of Pleasure”. OTC Opiates. Opium. Smoker. Opium in San Francisco. Gentlemen prefer…opium. Bob Sammons, M.D., Ph.D.. Mesa Behavioral Medicine Clinic. TMS Solutions. Conflict of interest. None.      Dr. Sammons received a bachelors and master’s degree from Auburn University, a PhD in clinical psychology from the University of North Carolina at Greensboro, and a medical degree from the University of North Carolina at Chapel Hill.  He did a residency in psychiatry at the University of Virginia as well as a forensic fellowship.  While serving in the United States Air Force as a squad commander and captain, he was selected as one of 5 psychologist to establish the opiate treatment phase of the drug treatment program for the Department of Air Force in 1972.  For this he receive the  Meritorious Service Medal.  He has practiced adult psychiatry in Grand Junction for 28 years.  He is 1 of 2 physicians in town that have received specialist training and a special DEA number that allows him to prescribe Suboxone treatment for opiate dependency.. Section I: welcome and introductions. 2. Name Tent. 3. Years of service. Experience with families experiencing opioid use or addiction?. Personal goal for this training. NAME. County. . Learning Objectives:. Jim Ryser, MA, LMHC, LCAC, CADAC II, ICDAC. Program Manager, Pain Services. IU Health Methodist. 317.962.0651. Disease – Behavior and Stigma . STD’s. Obesity. Tobacco assisted CV. HIV – coming around. . Learning Objectives:. Identify the impact of opioid use, addiction, and recovery on child development. Identify warning signs of opioid . use and abuse. Discuss the five components of recovery. ?. How has the opioid epidemic impacted emergency room related costs. ?. How has the opioid epidemic involved families as part of . the solution. ?. How has the opioid epidemic involved education as part of the solution. Zoe Boomgarden and Danny Peters. Identity. Hydrocodone (dihydrocodeinone) is a semi-synthetic opioid. Often taken in conjunction with acetaminophen, ibuprofen, or aspirin. Examples of prescription drugs: Vicodin, Lorcet, Lortab, Hycet etc. . Melissa A. Soliz, Esq., Coppersmith Brockelman PLC. msoliz@cblawyers.com. Bio: . http://www.cblawyers.com/melissa-soliz. /. . February 20, 2018. Agenda. Introduction: the opioid epidemic at the state and national level. Ernest J Dole, PharmD, . PhC. , FASHP, BCPS. Clinical Pharmacist & . Asso. . Clinical Prof.. University of New Mexico Hospitals & College of Pharmacy. Albuquerque, NM. Learning Objectives. At the end of this presentation, utilizing a case of an older patient on chronic opioid therapy (COT) with the comorbidity of geriatric opioid abuse (GOA) the participant will be able to. MAT BASICS Peter Mason MD Medical Director Region 1 IDN Opioid Use Disorder (OUD) Opioid Use Disorder (OUD): A medical condition characterized by a problematic pattern of opioid use that causes clinically significant impairment or distress. Medication Assisted Treatment (MAT) & Overdose Prevention. Michael Baca-Atlas, MD. Addiction Medicine . Fellow. UNC . School of . Medicine. June 14, 2019. Disclosures. The presenter has nothing to . For Providers and Primary Care Teams. Medication Treatment for Opioid . U. se . D. isorder. Developer: . Joe Merrill, MD, University of . Washington,. Charles Morgan MD, and Anne . Griepp. MD, Western New York Collaborative. Stephanie Foster. Weinshenker Lab. Rollins Program in SUD Talk. 12.10.19. Basic science approach to addiction research. Characterize 1) changes that drugs induce in the brain and 2) factors that may increase susceptibility.